Pushing the boundaries in pharmaceutical hit discovery with the novel waveRAPID kinetic assay Creoptix

In this application note, conducted by an HTS drug discovery group, Creoptix demonstrates how the waveRAPID can be used to streamline the kinetic characterization of large numbers of drug hit compounds, with results comparable to traditional SPR and high reproducibility.